Mental health comorbidities are more prevalent among transgender and gender nonconforming adults with IBD than the general and IBD US populations.

Risankizumab for Crohn disease taken over a long-term extension results in clinically meaningful sustained HRQOL improvements.

Ileosigmoid fistulas in Crohn disease are surgically managed in varying ways, which suggests a need for standardized guidelines.

No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.